{"transactions":[{"id":1014478,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-10-22T22:57:28.000Z","date":"2025-10-21","kind":"sale","planned":false,"acquired":false,"shares":4000000,"price":2.7685,"value":11074000.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":2379194,"source":{"system":"sec-edgar","filing":"0001104659-25-101613","document":"tm2529290-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000110465925101613/tm2529290-2_4seq1.xml","form_type":"4"}},{"id":1014477,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-10-22T22:57:28.000Z","date":"2025-10-20","kind":"sale","planned":false,"acquired":false,"shares":1923000,"price":2.4115,"value":4637314.5,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. (\"Rani\"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6379194,"source":{"system":"sec-edgar","filing":"0001104659-25-101613","document":"tm2529290-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1856725/000110465925101613/tm2529290-2_4seq1.xml","form_type":"4"}},{"id":1384518,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-10-17T16:30:19.000Z","date":"2024-10-15","kind":"sale","planned":false,"acquired":false,"shares":523738,"price":3.2562,"value":1705395.6756,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":8302194,"source":{"system":"sec-edgar","filing":"0001104659-24-109543","document":"tm2426414-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465924109543/tm2426414-2_4seq1.xml","form_type":"4"}},{"id":1384517,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-10-17T16:30:19.000Z","date":"2024-10-15","kind":"sale","planned":false,"acquired":false,"shares":3305622,"price":2.5521,"value":8436277.9062,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. (\"Rani\"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. (\"Rani\"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":8825932,"source":{"system":"sec-edgar","filing":"0001104659-24-109543","document":"tm2426414-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465924109543/tm2426414-2_4seq1.xml","form_type":"4"}},{"id":1717380,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-08T16:27:22.000Z","date":"2023-11-24","kind":"purchase","planned":false,"acquired":true,"shares":5265165,"price":2.01,"value":10582981.65,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired 5,265,165 shares of the Issuer's Class A Common Stock in a private secondary offering that was priced at the prevailing market price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":12131554,"source":{"system":"sec-edgar","filing":"0001104659-23-124719","document":"tm2332512-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923124719/tm2332512-2_4seq1.xml","form_type":"4"}},{"id":1892977,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-15T16:22:36.000Z","date":"2023-05-12","kind":"purchase","planned":false,"acquired":true,"shares":2645,"price":3.9809,"value":10529.4805,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6866389,"source":{"system":"sec-edgar","filing":"0001104659-23-060817","document":"tm2314845-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923060817/tm2314845-3_4seq1.xml","form_type":"4"}},{"id":1892976,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-15T16:22:36.000Z","date":"2023-05-11","kind":"purchase","planned":false,"acquired":true,"shares":2610,"price":3.8683,"value":10096.263,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.78 to $3.99 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6863744,"source":{"system":"sec-edgar","filing":"0001104659-23-060817","document":"tm2314845-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923060817/tm2314845-3_4seq1.xml","form_type":"4"}},{"id":1897772,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-10T16:25:09.000Z","date":"2023-05-08","kind":"purchase","planned":false,"acquired":true,"shares":4420,"price":4.4645,"value":19733.09,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6861134,"source":{"system":"sec-edgar","filing":"0001104659-23-058462","document":"tm2314845-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923058462/tm2314845-2_4seq1.xml","form_type":"4"}},{"id":1902166,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-05T13:26:42.000Z","date":"2023-05-03","kind":"purchase","planned":false,"acquired":true,"shares":2040,"price":4.8118,"value":9816.072,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.83 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6856714,"source":{"system":"sec-edgar","filing":"0001104659-23-056424","document":"tm2314845-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923056424/tm2314845-1_4seq1.xml","form_type":"4"}},{"id":1907798,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-02T13:09:37.000Z","date":"2023-04-28","kind":"purchase","planned":false,"acquired":true,"shares":2173,"price":4.7055,"value":10225.0515,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.645 to $4.80 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6854674,"source":{"system":"sec-edgar","filing":"0001104659-23-054940","document":"tm2311848-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923054940/tm2311848-9_4seq1.xml","form_type":"4"}},{"id":1913129,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-26T17:09:25.000Z","date":"2023-04-25","kind":"purchase","planned":false,"acquired":true,"shares":4423,"price":4.511,"value":19952.153,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.39 to $4.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6852501,"source":{"system":"sec-edgar","filing":"0001104659-23-050432","document":"tm2311848-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923050432/tm2311848-8_4seq1.xml","form_type":"4"}},{"id":1913128,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-26T17:09:25.000Z","date":"2023-04-24","kind":"purchase","planned":false,"acquired":true,"shares":4280,"price":4.6716,"value":19994.448,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.705 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6848078,"source":{"system":"sec-edgar","filing":"0001104659-23-050432","document":"tm2311848-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923050432/tm2311848-8_4seq1.xml","form_type":"4"}},{"id":1914705,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-24T17:25:03.000Z","date":"2023-04-21","kind":"purchase","planned":false,"acquired":true,"shares":4100,"price":4.9326,"value":20223.66,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6843798,"source":{"system":"sec-edgar","filing":"0001104659-23-049097","document":"tm2311848-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923049097/tm2311848-7_4seq1.xml","form_type":"4"}},{"id":1914704,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-24T17:25:03.000Z","date":"2023-04-20","kind":"purchase","planned":false,"acquired":true,"shares":1850,"price":5.3246,"value":9850.51,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.32 to $5.38 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6839698,"source":{"system":"sec-edgar","filing":"0001104659-23-049097","document":"tm2311848-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923049097/tm2311848-7_4seq1.xml","form_type":"4"}},{"id":1916205,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-20T15:23:19.000Z","date":"2023-04-18","kind":"purchase","planned":false,"acquired":true,"shares":1850,"price":5.3724,"value":9938.94,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6837848,"source":{"system":"sec-edgar","filing":"0001104659-23-047682","document":"tm2311848-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923047682/tm2311848-6_4seq1.xml","form_type":"4"}},{"id":1917774,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-18T13:50:52.000Z","date":"2023-04-14","kind":"purchase","planned":false,"acquired":true,"shares":1901,"price":5.2704,"value":10019.0304,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.20 to $5.29 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6835998,"source":{"system":"sec-edgar","filing":"0001104659-23-046614","document":"tm2311848-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923046614/tm2311848-5_4seq1.xml","form_type":"4"}},{"id":1919344,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-14T16:21:05.000Z","date":"2023-04-13","kind":"purchase","planned":false,"acquired":true,"shares":890,"price":5.465,"value":4863.85,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6834097,"source":{"system":"sec-edgar","filing":"0001104659-23-045603","document":"tm2312872-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923045603/tm2312872-1_4seq.xml","form_type":"4"}},{"id":1919343,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-14T16:21:05.000Z","date":"2023-04-12","kind":"purchase","planned":false,"acquired":true,"shares":3577,"price":5.4753,"value":19585.1481,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.405 to $5.59 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6833207,"source":{"system":"sec-edgar","filing":"0001104659-23-045603","document":"tm2312872-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923045603/tm2312872-1_4seq.xml","form_type":"4"}},{"id":1920709,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-12T12:22:39.000Z","date":"2023-04-11","kind":"purchase","planned":false,"acquired":true,"shares":1765,"price":5.5784,"value":9845.876,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.57 to $5.66 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6829630,"source":{"system":"sec-edgar","filing":"0001104659-23-044438","document":"tm2311848-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923044438/tm2311848-4_4seq1.xml","form_type":"4"}},{"id":1920708,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-12T12:22:39.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":1923,"price":5.0672,"value":9744.2256,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6827865,"source":{"system":"sec-edgar","filing":"0001104659-23-044438","document":"tm2311848-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923044438/tm2311848-4_4seq1.xml","form_type":"4"}},{"id":1922119,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-10T13:54:54.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":7551,"price":5.1351,"value":38775.1401,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.24 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6825942,"source":{"system":"sec-edgar","filing":"0001104659-23-043508","document":"tm2311848-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923043508/tm2311848-3_4seq1.xml","form_type":"4"}},{"id":1923407,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-06T13:16:13.000Z","date":"2023-04-05","kind":"purchase","planned":false,"acquired":true,"shares":7280,"price":5.487,"value":39945.36,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.42 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6818391,"source":{"system":"sec-edgar","filing":"0001104659-23-042563","document":"tm2311848-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923042563/tm2311848-2_4seq1.xml","form_type":"4"}},{"id":1923406,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-06T13:16:13.000Z","date":"2023-04-04","kind":"purchase","planned":false,"acquired":true,"shares":4416,"price":5.4906,"value":24246.4896,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.43 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6811111,"source":{"system":"sec-edgar","filing":"0001104659-23-042563","document":"tm2311848-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923042563/tm2311848-2_4seq1.xml","form_type":"4"}},{"id":1924466,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-05T11:48:46.000Z","date":"2023-04-03","kind":"purchase","planned":false,"acquired":true,"shares":3587,"price":5.2268,"value":18748.5316,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.35 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6806695,"source":{"system":"sec-edgar","filing":"0001104659-23-041984","document":"tm2311848-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923041984/tm2311848-1_4seq1.xml","form_type":"4"}},{"id":1931741,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-03T14:16:18.000Z","date":"2023-03-31","kind":"purchase","planned":false,"acquired":true,"shares":751,"price":5.0476,"value":3790.7476,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.95 to $5.12 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6803108,"source":{"system":"sec-edgar","filing":"0001104659-23-040729","document":"tm238347d10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923040729/tm238347d10_4seq1.xml","form_type":"4"}},{"id":1931740,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-03T14:16:18.000Z","date":"2023-03-30","kind":"purchase","planned":false,"acquired":true,"shares":12230,"price":4.7901,"value":58582.923,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $5.58 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6802357,"source":{"system":"sec-edgar","filing":"0001104659-23-040729","document":"tm238347d10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923040729/tm238347d10_4seq1.xml","form_type":"4"}},{"id":1934686,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-30T14:51:59.000Z","date":"2023-03-28","kind":"purchase","planned":false,"acquired":true,"shares":3510,"price":5.4937,"value":19282.887,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.40 to $5.605 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6790127,"source":{"system":"sec-edgar","filing":"0001104659-23-039082","document":"tm238347-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923039082/tm238347-9_4seq1.xml","form_type":"4"}},{"id":1941098,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-22T12:48:44.000Z","date":"2023-03-21","kind":"purchase","planned":false,"acquired":true,"shares":3230,"price":6.0796,"value":19637.108,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.00 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6786617,"source":{"system":"sec-edgar","filing":"0001104659-23-035492","document":"tm238347-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923035492/tm238347-8_4seq1.xml","form_type":"4"}},{"id":1941097,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-22T12:48:44.000Z","date":"2023-03-20","kind":"purchase","planned":false,"acquired":true,"shares":532,"price":6.2926,"value":3347.6632,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.27 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6783387,"source":{"system":"sec-edgar","filing":"0001104659-23-035492","document":"tm238347-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923035492/tm238347-8_4seq1.xml","form_type":"4"}},{"id":1944071,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-20T12:13:55.000Z","date":"2023-03-17","kind":"purchase","planned":false,"acquired":true,"shares":2980,"price":6.1906,"value":18447.988,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.10 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6782855,"source":{"system":"sec-edgar","filing":"0001104659-23-034345","document":"tm238347-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923034345/tm238347-7_4seq1.xml","form_type":"4"}},{"id":1944070,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-20T12:13:55.000Z","date":"2023-03-16","kind":"purchase","planned":false,"acquired":true,"shares":1325,"price":6.072,"value":8045.4,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.02 to $6.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6779875,"source":{"system":"sec-edgar","filing":"0001104659-23-034345","document":"tm238347-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923034345/tm238347-7_4seq1.xml","form_type":"4"}},{"id":1951647,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-15T11:15:34.000Z","date":"2023-03-13","kind":"purchase","acquired":true,"shares":2463,"price":6.1391,"value":15120.6033,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.06 to $6.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6778550,"source":{"system":"sec-edgar","filing":"0001104659-23-032652","document":"tm238347-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923032652/tm238347-6_4seq1.xml","form_type":"4"}},{"id":1958203,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-10T14:48:18.000Z","date":"2023-03-09","kind":"purchase","acquired":true,"shares":3730,"price":6.5649,"value":24487.077,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.45 to $6.67 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6776087,"source":{"system":"sec-edgar","filing":"0001104659-23-031099","document":"tm238347-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923031099/tm238347-4_4seq1.xml","form_type":"4"}},{"id":1958202,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-10T14:48:18.000Z","date":"2023-03-08","kind":"purchase","acquired":true,"shares":1702,"price":6.5818,"value":11202.2236,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.505 to $6.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6772357,"source":{"system":"sec-edgar","filing":"0001104659-23-031099","document":"tm238347-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923031099/tm238347-4_4seq1.xml","form_type":"4"}},{"id":1962451,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-08T10:10:38.000Z","date":"2023-03-06","kind":"purchase","acquired":true,"shares":1100,"price":6.3927,"value":7031.97,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.36 to $6.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6770655,"source":{"system":"sec-edgar","filing":"0001104659-23-029919","document":"tm238347-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923029919/tm238347-3_4seq1.xml","form_type":"4"}},{"id":1967999,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-06T15:26:51.000Z","date":"2023-03-02","kind":"purchase","acquired":true,"shares":3900,"price":6.31,"value":24609.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in a single transaction at a price of $6.31 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6769555,"source":{"system":"sec-edgar","filing":"0001104659-23-028960","document":"tm238347-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923028960/tm238347-2_4seq1.xml","form_type":"4"}},{"id":1978341,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-02T12:14:45.000Z","date":"2023-02-28","kind":"purchase","acquired":true,"shares":711,"price":6.2986,"value":4478.3046,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.29 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6765655,"source":{"system":"sec-edgar","filing":"0001104659-23-027777","document":"tm238347-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923027777/tm238347-1_4seq1.xml","form_type":"4"}},{"id":1985876,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-28T11:24:39.000Z","date":"2023-02-27","kind":"purchase","acquired":true,"shares":3541,"price":6.3,"value":22308.3,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were purchased in multiple transactions, each at $6.30 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6764944,"source":{"system":"sec-edgar","filing":"0001104659-23-026516","document":"tm237665-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923026516/tm237665-2_4seq1.xml","form_type":"4"}},{"id":1985875,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-28T11:24:39.000Z","date":"2023-02-24","kind":"purchase","acquired":true,"shares":5451,"price":6.0869,"value":33179.6919,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.01 to $6.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6761403,"source":{"system":"sec-edgar","filing":"0001104659-23-026516","document":"tm237665-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923026516/tm237665-2_4seq1.xml","form_type":"4"}},{"id":1995155,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-23T15:17:16.000Z","date":"2023-02-22","kind":"purchase","acquired":true,"shares":1000,"price":6.1,"value":6100.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were purchased in multiple transactions, each at $6.10 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6755952,"source":{"system":"sec-edgar","filing":"0001104659-23-024727","document":"tm237665-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923024727/tm237665-1_4seq1.xml","form_type":"4"}},{"id":1995154,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-23T15:17:16.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":3080,"price":5.9415,"value":18299.82,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.85 to $6.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6754952,"source":{"system":"sec-edgar","filing":"0001104659-23-024727","document":"tm237665-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923024727/tm237665-1_4seq1.xml","form_type":"4"}},{"id":2002739,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-21T10:37:18.000Z","date":"2023-02-17","kind":"purchase","acquired":true,"shares":8468,"price":5.88,"value":49791.84,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.72 to $6.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6751872,"source":{"system":"sec-edgar","filing":"0001104659-23-023608","document":"tm237324-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923023608/tm237324-1_4seq1.xml","form_type":"4"}},{"id":2002738,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-21T10:37:18.000Z","date":"2023-02-16","kind":"purchase","acquired":true,"shares":9500,"price":5.4869,"value":52125.55,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.21 to $5.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6743404,"source":{"system":"sec-edgar","filing":"0001104659-23-023608","document":"tm237324-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923023608/tm237324-1_4seq1.xml","form_type":"4"}},{"id":2010401,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-16T12:50:29.000Z","date":"2023-02-15","kind":"purchase","acquired":true,"shares":10000,"price":5.2049,"value":52049.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.08 to $5.25 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6733904,"source":{"system":"sec-edgar","filing":"0001104659-23-022702","document":"tm237124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923022702/tm237124-1_4seq1.xml","form_type":"4"}},{"id":2010400,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-16T12:50:29.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":9250,"price":5.2501,"value":48563.425,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.995 to $5.52 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6723904,"source":{"system":"sec-edgar","filing":"0001104659-23-022702","document":"tm237124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923022702/tm237124-1_4seq1.xml","form_type":"4"}},{"id":2071987,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-03T20:08:32.000Z","date":"2022-12-30","kind":"purchase","acquired":true,"shares":8600,"price":5.9828,"value":51452.08,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.80 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6714654,"source":{"system":"sec-edgar","filing":"0001104659-23-000498","document":"tm2231865-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923000498/tm2231865-7_4seq1.xml","form_type":"4"}},{"id":2071986,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-01-03T20:08:32.000Z","date":"2022-12-29","kind":"purchase","acquired":true,"shares":8600,"price":5.9662,"value":51309.32,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.75 to $6.23 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6706054,"source":{"system":"sec-edgar","filing":"0001104659-23-000498","document":"tm2231865-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465923000498/tm2231865-7_4seq1.xml","form_type":"4"}},{"id":2074756,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-29T15:23:43.000Z","date":"2022-12-28","kind":"purchase","acquired":true,"shares":9157,"price":5.5757,"value":51056.6849,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.42 to $5.71 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6697454,"source":{"system":"sec-edgar","filing":"0001104659-22-130920","document":"tm2231865-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922130920/tm2231865-6_4seq1.xml","form_type":"4"}},{"id":2079346,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-20T14:57:54.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":6900,"price":7.4325,"value":51284.25,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.60 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6688297,"source":{"system":"sec-edgar","filing":"0001104659-22-128587","document":"tm2232650-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922128587/tm2232650-4_4seq1.xml","form_type":"4"}},{"id":2079345,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-20T14:57:54.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":6400,"price":7.7638,"value":49688.32,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.36 to $8.09 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6681397,"source":{"system":"sec-edgar","filing":"0001104659-22-128587","document":"tm2232650-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922128587/tm2232650-4_4seq1.xml","form_type":"4"}},{"id":2083166,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-16T16:13:53.000Z","date":"2022-12-15","kind":"purchase","acquired":true,"shares":6500,"price":7.9528,"value":51693.2,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.74 to $8.24 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6674997,"source":{"system":"sec-edgar","filing":"0001104659-22-127821","document":"tm2231865-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922127821/tm2231865-5_4seq1.xml","form_type":"4"}},{"id":2083165,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-16T16:13:53.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":7027,"price":8.0102,"value":56287.6754,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.86 to $8.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6668497,"source":{"system":"sec-edgar","filing":"0001104659-22-127821","document":"tm2231865-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922127821/tm2231865-5_4seq1.xml","form_type":"4"}},{"id":2084726,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T12:43:39.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":5732,"price":2.7917,"value":16002.0244,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.80 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14867592,"source":{"system":"sec-edgar","filing":"0001104659-22-127246","document":"tm2232650-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922127246/tm2232650-3_4seq1.xml","form_type":"4"}},{"id":2084725,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T12:43:39.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":36230,"price":2.7133,"value":98302.859,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.76 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14861860,"source":{"system":"sec-edgar","filing":"0001104659-22-127246","document":"tm2232650-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922127246/tm2232650-3_4seq1.xml","form_type":"4"}},{"id":2086069,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-14T12:42:29.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":12050,"price":8.2131,"value":98967.855,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.04 to $8.30 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6658678,"source":{"system":"sec-edgar","filing":"0001104659-22-126906","document":"tm2232650-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126906/tm2232650-2_4seq1.xml","form_type":"4"}},{"id":2086068,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-14T12:42:29.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":12500,"price":8.0378,"value":100472.5,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $8.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6646628,"source":{"system":"sec-edgar","filing":"0001104659-22-126906","document":"tm2232650-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126906/tm2232650-2_4seq1.xml","form_type":"4"}},{"id":2087385,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T19:35:01.000Z","date":"2022-12-12","kind":"purchase","acquired":true,"shares":39200,"price":2.6445,"value":103664.4,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.53 to $2.72 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14825630,"source":{"system":"sec-edgar","filing":"0001104659-22-126735","document":"tm2232650-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126735/tm2232650-1_4seq1.xml","form_type":"4"}},{"id":2087384,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-13T19:35:01.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":2800,"price":2.5968,"value":7271.04,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.59 to $2.60 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14786430,"source":{"system":"sec-edgar","filing":"0001104659-22-126735","document":"tm2232650-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126735/tm2232650-1_4seq1.xml","form_type":"4"}},{"id":2089223,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-12T12:28:35.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":12345,"price":8.0139,"value":98931.5955,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.875 to $8.10 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6634128,"source":{"system":"sec-edgar","filing":"0001104659-22-126159","document":"tm2231865-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126159/tm2231865-4_4seq1.xml","form_type":"4"}},{"id":2089222,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-12T12:28:35.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":12195,"price":7.9347,"value":96763.6665,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.72 to $8.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6621783,"source":{"system":"sec-edgar","filing":"0001104659-22-126159","document":"tm2231865-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922126159/tm2231865-4_4seq1.xml","form_type":"4"}},{"id":2090736,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-09T12:34:40.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":10755,"price":2.3944,"value":25751.772,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.38 to $2.40 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14783630,"source":{"system":"sec-edgar","filing":"0001104659-22-125744","document":"tm2232355-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125744/tm2232355-1_4seq1.xml","form_type":"4"}},{"id":2090735,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-09T12:34:40.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":41666,"price":2.2176,"value":92398.5216,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.065 to $2.40 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14772875,"source":{"system":"sec-edgar","filing":"0001104659-22-125744","document":"tm2232355-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125744/tm2232355-1_4seq1.xml","form_type":"4"}},{"id":2091936,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-08T11:31:24.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":600,"price":7.9413,"value":4764.78,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $7.98 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6609588,"source":{"system":"sec-edgar","filing":"0001104659-22-125384","document":"tm2231865-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125384/tm2231865-3_4seq1.xml","form_type":"4"}},{"id":2091935,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-08T11:31:24.000Z","date":"2022-12-06","kind":"purchase","acquired":true,"shares":12500,"price":7.4491,"value":93113.75,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.10 to $7.875 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6608988,"source":{"system":"sec-edgar","filing":"0001104659-22-125384","document":"tm2231865-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125384/tm2231865-3_4seq1.xml","form_type":"4"}},{"id":2092951,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-07T14:35:54.000Z","date":"2022-12-06","kind":"purchase","acquired":true,"shares":41600,"price":2.2584,"value":93949.44,"ownership":{"direct":false,"nature":"Shares indirectly held through Soth Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.31 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14731209,"source":{"system":"sec-edgar","filing":"0001104659-22-125143","document":"tm2232186-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125143/tm2232186-1_4seq1.xml","form_type":"4"}},{"id":2092950,"issuer":{"id":7353,"kind":"organization","name":"FTC Solar, Inc."},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-07T14:35:54.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":36859,"price":2.39,"value":88093.01,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.40 per share, inclusive. The reporting persons undertake to provide FTC Solar, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":14689609,"source":{"system":"sec-edgar","filing":"0001104659-22-125143","document":"tm2232186-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922125143/tm2232186-1_4seq1.xml","form_type":"4"}},{"id":2094064,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-06T11:34:16.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":12195,"price":7.9685,"value":97175.8575,"ownership":{"direct":false,"nature":"Shares indirectly held through Soth Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.74 to $8.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6596488,"source":{"system":"sec-edgar","filing":"0001104659-22-124794","document":"tm2231865-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922124794/tm2231865-2_4seq1.xml","form_type":"4"}},{"id":2094063,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-06T11:34:16.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":9819,"price":8.1613,"value":80135.8047,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6584293,"source":{"system":"sec-edgar","filing":"0001104659-22-124794","document":"tm2231865-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922124794/tm2231865-2_4seq1.xml","form_type":"4"}},{"id":2097702,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-02T13:57:04.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":202,"price":8,"value":1616.0,"ownership":{"direct":false,"nature":"Shares indirectly held through Soth Lake One LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6574474,"source":{"system":"sec-edgar","filing":"0001104659-22-124012","document":"tm2231865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922124012/tm2231865-1_4seq1.xml","form_type":"4"}},{"id":2097701,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-02T13:57:04.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":8000,"price":7.928,"value":63424.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.785 to $8.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6574272,"source":{"system":"sec-edgar","filing":"0001104659-22-124012","document":"tm2231865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922124012/tm2231865-1_4seq1.xml","form_type":"4"}},{"id":2101089,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-30T14:13:23.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":3720,"price":7.9536,"value":29587.392,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.645 to $8.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6566272,"source":{"system":"sec-edgar","filing":"0001104659-22-123153","document":"tm2231288-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922123153/tm2231288-3_4seq1.xml","form_type":"4"}},{"id":2103120,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-28T13:59:25.000Z","date":"2022-11-25","kind":"purchase","acquired":true,"shares":800,"price":7.8388,"value":6271.04,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.70 to $8.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6562552,"source":{"system":"sec-edgar","filing":"0001104659-22-122333","document":"tm2231288-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922122333/tm2231288-2_4seq1.xml","form_type":"4"}},{"id":2103119,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-28T13:59:25.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":3396,"price":7.8406,"value":26626.6776,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.55 to $7.99 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6561752,"source":{"system":"sec-edgar","filing":"0001104659-22-122333","document":"tm2231288-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922122333/tm2231288-2_4seq1.xml","form_type":"4"}},{"id":2104807,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-23T12:23:33.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":12500,"price":7.3239,"value":91548.75,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.60 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"South Cone Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6558356,"source":{"system":"sec-edgar","filing":"0001104659-22-121604","document":"tm2231288-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922121604/tm2231288-1_4seq1.xml","form_type":"4"}},{"id":2104806,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-23T12:23:33.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":3200,"price":7.8734,"value":25194.88,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.73 to $8.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"South Cone Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6545856,"source":{"system":"sec-edgar","filing":"0001104659-22-121604","document":"tm2231288-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922121604/tm2231288-1_4seq1.xml","form_type":"4"}},{"id":2104805,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":1,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86699,"kind":"organization","name":"South Lake One LLC","position":2,"cik":"0001794292","reported_name":"South Lake One LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-11-23T12:23:33.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":13300,"price":7.493,"value":99656.9,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.82 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"South Cone Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC."}],"balance_after":6542656,"source":{"system":"sec-edgar","filing":"0001104659-22-121604","document":"tm2231288-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794292/000110465922121604/tm2231288-1_4seq1.xml","form_type":"4"}},{"id":2616631,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":136666,"kind":"person","name":"Quiroga Moreno Isidoro","position":1,"cik":"0001794307","reported_name":"Quiroga Moreno Isidoro","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":2,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-03T17:59:04.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":3572727,"price":11,"value":39299997.0,"ownership":{"direct":false,"nature":"Shares indirectly held through South Lake One LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Issuer's initial public offering, South Lake One LLC (\"South Lake\") acquired, at a price of $11.00 per share of Class A Common Stock, 3,572,727 shares of the Issuer's Class A Common Stock for an aggregate purchase price of $39,299,997."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Isidoro Quiroga Moreno indirectly controls South Lake, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. South Lake is wholly owned by South Cone, which is controlled by its general partner El Aromo, which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo)."}],"balance_after":11731654,"source":{"system":"sec-edgar","filing":"0001104659-21-099595","document":"tm2124024-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1794307/000110465921099595/tm2124024-2_4seq1.xml","form_type":"4"}},{"id":2616630,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":136666,"kind":"person","name":"Quiroga Moreno Isidoro","position":1,"cik":"0001794307","reported_name":"Quiroga Moreno Isidoro","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":2,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-03T17:59:04.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":2727273,"price":11,"value":30000003.0,"ownership":{"direct":false,"nature":"Shares indirectly held through Aequanimitas Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the Issuer's initial public offering, Aequanimitas acquired, at a price of $11.00 per share of Class A Common Stock, 2,727,273 shares of the Issuer's Class A Common Stock for an aggregate purchase price of $30,000,003."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Isidoro Quiroga Moreno indirectly controls Aequanimitas, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. Aequanimitas is controlled by its general partner, South Lake Three LLC, which is wholly owned by South Cone Investments Limited Partnership (\"South Cone\"), which is controlled by its general partner Inversiones El Aromo Limitada (\"El Aromo\"), which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo)."}],"balance_after":8158927,"source":{"system":"sec-edgar","filing":"0001104659-21-099595","document":"tm2124024-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1794307/000110465921099595/tm2124024-2_4seq1.xml","form_type":"4"}},{"id":2616629,"issuer":{"id":6642,"kind":"organization","name":"Rani Therapeutics Holdings, Inc.","symbol":"RANI"},"owners":[{"id":136666,"kind":"person","name":"Quiroga Moreno Isidoro","position":1,"cik":"0001794307","reported_name":"Quiroga Moreno Isidoro","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74044,"kind":"organization","name":"South Cone Investments Limited Partnership","position":2,"cik":"0001876412","reported_name":"South Cone Investments Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-08-03T17:59:04.000Z","date":"2021-07-30","kind":"purchase","acquired":true,"shares":158904,"price":11.2525,"value":1788067.26,"ownership":{"direct":false,"nature":"Shares indirectly held through Aequanimitas Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Aequanimitas Limited Partnership (\"Aequanimitas\") acquired 158,904 shares of the Issuer's Class A Common Stock in a single transaction in the open market at a price of $11.2525 per share of Class A Common Stock for an aggregate purchase price of $1,788,067.26."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Isidoro Quiroga Moreno indirectly controls Aequanimitas, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. Aequanimitas is controlled by its general partner, South Lake Three LLC, which is wholly owned by South Cone Investments Limited Partnership (\"South Cone\"), which is controlled by its general partner Inversiones El Aromo Limitada (\"El Aromo\"), which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo)."}],"balance_after":5431654,"source":{"system":"sec-edgar","filing":"0001104659-21-099595","document":"tm2124024-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1794307/000110465921099595/tm2124024-2_4seq1.xml","form_type":"4"}}]}